Concepedia

Avital Lev

AL

Statistics

Publications

17

Citations

814

H-Index

16

Active since

2002

Affiliations

Technion – Israel Institute of Technology(Current)

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Fox Chase Cancer Center

Tel Aviv University

Avital Lev is an author at Technion – Israel Institute of Technology specializing in immunology, life sciences, and mhc-peptide recognition.

Publications per year

2002–2021

17

Publications

17

Host ER–parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in <i>Toxoplasma gondii</i> –infected dendritic cells

Romina S. Goldszmid, Isabelle Coppens, Avital Lev et al. · The Journal of Experimental Medicine · 2009 · 144 citations · Full text

, , +17

Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.

Avital Lev, Galit Denkberg, Cyril J. Cohen et al. · PubMed · 2002 · 99 citations

, , +17

Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity

Galit Denkberg, Cyril J. Cohen, Avital Lev et al. · Proceedings of the National Academy of Sciences · 2002 · 92 citations

, , +17

Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action

Avital Lev, Michael F. Princiotta, Damien Zanker et al. · Proceedings of the National Academy of Sciences · 2010 · 63 citations · Full text

, , +17

The Exception that Reinforces the Rule: Crosspriming by Cytosolic Peptides that Escape Degradation

Avital Lev, Kazuyo Takeda, Damien Zanker et al. · Immunity · 2008 · 62 citations · Full text

, , +7

1–5 of 17